SCHEMBL25822847

SCHEMBL25822847

Nc1ncnc2c1c(-c1cc(CO)c(NC(=O)Nc3cc(C4(C(F)(F)F)CC4)on3)cc1F)nn2C1CC1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NEK7 Q8TDX7 18/20 0.60
BTK Q06187 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24096854 0.92 NEK7 (0.65) NEK7BTK
SCHEMBL30320633 0.92 NEK7 (0.65) NEK7BTK
SCHEMBL25818017 0.91 NEK7 (0.48) NEK7BTK
SCHEMBL30500109 0.88 NEK7 (0.62) NEK7
SCHEMBL24096526 0.88 NEK7 (0.62) NEK7
SCHEMBL30320636 0.84 NEK7 (0.75) NEK7
SCHEMBL24096497 0.84 NEK7 (0.75) NEK7
SCHEMBL25818010 0.83 NEK7 (0.52) NEK7BTK
SCHEMBL24096802 0.81 NEK7 (0.61) NEK7BTK
SCHEMBL30320463 0.81 NEK7 (0.64) NEK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203045-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203045-A1 INHIBITORS OF NEK7 KINASE NEK7, NEK1, NEK5 NEK7 1/4885BTK 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.